Trial intelligence / Profile preview

Macroflux PTH Patch vs Placebo and Forteo in Postmenopausal Osteoporosis

NCT00489918Phase 2Completed

Sponsor
Zosano Pharma
Start
Jun 2007
Primary completion
Apr 2008
Modality
Peptides
01

Overview

A Phase 2 trial of Osteofortil in osteoporosis, sponsored by Zosano Pharma. Started Jun 2007; status: completed.

02

Drugs

Osteofortil
03

Conditions

osteoporosis

Beyond the preview

Go deeper on NCT00489918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00489918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call